CHEBI:87016 - eslicarbazepine acetate

ChEBI IDCHEBI:87016
ChEBI Nameeslicarbazepine acetate
Stars
DefinitionThe acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy.
Last Modified12 March 2019
SubmitterMarcus Ennis
DownloadsMolfile
FormulaC17H16N2O3
Net Charge0
Average Mass296.326
Monoisotopic Mass296.11609
SMILESCC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21
InChIInChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1
InChIKeyQIALRBLEEWJACW-INIZCTEOSA-N
Roles Classification
Biological Role:
drug allergen  Any drug which causes the onset of an allergic reaction.
Applications:
drug allergen  Any drug which causes the onset of an allergic reaction.
antipsychotic agent  Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
anticonvulsant  A drug used to prevent seizures or reduce their severity.
ChEBI Ontology
Outgoing Relation(s)
eslicarbazepine acetate (CHEBI:87016) has functional parent licarbazepine (CHEBI:701)
eslicarbazepine acetate (CHEBI:87016) has role anticonvulsant (CHEBI:35623)
eslicarbazepine acetate (CHEBI:87016) has role antipsychotic agent (CHEBI:35476)
eslicarbazepine acetate (CHEBI:87016) has role drug allergen (CHEBI:88188)
eslicarbazepine acetate (CHEBI:87016) is a acetate ester (CHEBI:47622)
eslicarbazepine acetate (CHEBI:87016) is a carboxamide (CHEBI:37622)
eslicarbazepine acetate (CHEBI:87016) is a dibenzoazepine (CHEBI:47804)
eslicarbazepine acetate (CHEBI:87016) is a ureas (CHEBI:47857)
IUPAC Name 
(10S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate
Synonyms  Source
(10S)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamideChEBI
BIA-2-093ChEMBL
BIA-2093ChEMBL
Eslicarbazepine acetateChEMBL
SEP - 0002093ChEMBL
SEP0002093ChEMBL
Brand Name  Source
ExaliefChEMBL
Manual XrefsDatabases
4303DrugCentral
Registry NumbersSources
CAS:236395-14-5ChemIDplus
Citations